Intuitive Surgical, Inc.
ISRG
Positions held
Your positionsISRG isn't in your positions.
Add it to see shares, cost, and P&L here.
Bull / bear case
Site-generated summary from fundamentals, news, and score — not investment advice. As of 2026-10-07.
- Intuitive Surgical operates in a growing industry with increasing demand for minimally invasive surgical procedures, positioning it well against competitors.
- In Q2 2026, revenue increased by 4% compared to the previous quarter, reaching $2.9 billion.
- The gross margin improved to 67.8%, up from 66.1% in the prior quarter.
- Despite strong performance, Intuitive Surgical faces high competition and regulatory scrutiny in the healthcare sector.
- The trailing P/E ratio stands at 46.42, indicating the stock may be overvalued compared to its earnings.
- Operating margin has only slightly expanded to 33.6%, suggesting limited room for operational improvement.
Fundamentals
| Market cap | $146.76B | Enterprise value | $141.67B | Trailing P/E | 47.64 | Forward P/E | 34.30 |
| PEG | 1.93 | Price / book | 8.09 | Beta | 1.46 | Dividend yield | 0.00% |
| Revenue growth | 18.5% | Earnings growth | 26.5% | Gross margin | 66.7% | Operating margin | 33.6% |
| Profit margin | 28.4% | ROE | 17.4% | ROA | 10.5% | Debt / equity | — |
| Current ratio | 4.96 | Free cash flow | $2.62B | Analyst recommendation | buy | Mean target | $477.47 |
| 52w high | $603.88 | 52w low | $328.57 |
Quarterly
| 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | |
|---|---|---|---|---|---|
| Revenue | $2.9B | $2.8B | $2.9B | $2.5B | $2.4B |
| Op margin | 33.6% | 30.9% | 30.2% | 30.3% | 30.5% |
| Net income | $818M | $822M | $795M | $704M | $658M |
| Gross margin | 67.8% | 66.1% | 66.4% | 66.4% | 66.3% |
| Gross profit | $2.0B | $1.8B | $1.9B | $1.7B | $1.6B |
| Operating income | $972M | $855M | $864M | $760M | $743M |
- Revenue +4% vs prior quarter ($2.9B vs $2.8B).
- Gross margin 67.8% (was 66.1% prior quarter).
- Operating margin expanded to 33.6%.
Yearly (6y)
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Revenue | $10.1B | $8.4B | $7.1B | $6.2B |
| Op margin | 29.3% | 28.1% | 24.8% | 25.3% |
| Net income | $2.9B | $2.3B | $1.8B | $1.3B |
| Gross margin | 66.0% | 67.5% | 66.4% | 67.4% |
| Gross profit | $6.6B | $5.6B | $4.7B | $4.2B |
| Operating income | $2.9B | $2.3B | $1.8B | $1.6B |
No flags
• No distress or material-risk keywords in recent headlines (keyword scan only — not a guarantee).
News
2026-10-09 · Leerink Partners Adjusts Price Target on Intuitive Surgical to $473 From $454
2026-10-08 · Is Intuitive Surgical (ISRG) a Buy as Wall Street Analysts Look Optimistic?
2026-10-08 · The Monopolistic Razor-and-Blade Engine I Can’t Stop Buying
2026-10-08 · 2 Profitable Stocks with Exciting Potential and 1 We Question
2026-10-08 · Should Barclays’ Bullish Initiation Amid Rising Rivalry Require Action From Intuitive Surgical (ISRG) Investors?
2026-10-07 · Intuitive Surgical (ISRG) and JNJ Give Jim Cramer More Than Valuation to Consider
2026-10-07 · Intuitive Surgical, Inc. (ISRG) Gains As Market Dips: What You Should Know
2026-10-07 · Can ISRG's Single-Port Platform Become the Next Billion-Dollar Franchise?
2026-10-07 · Flutter upgraded, AppFolio downgraded: Wall Street's top analyst calls
2026-10-07 · Jim Cramer Has Soured on Intuitive Surgical (ISRG). The Reason is Johnson & Johnson
2026-10-06 · What Could Lift ISRG Stock?
Price (daily)
Full chart · RSI · MACD · patterns